Mostrando 8 resultados de: 8
Subtipo de publicación
Article(8)
Publisher
Nature Communications(2)
BMC Infectious Diseases(1)
Cell(1)
Cell Reports(1)
Nature Microbiology(1)
Área temáticas
Enfermedades(6)
Microorganismos, hongos y algas(5)
Medicina y salud(4)
Fisiología humana(3)
Medicina forense; incidencia de enfermedades(3)
Origen
scopus(8)
Genomic epidemiology of SARS-CoV-2 in a university outbreak setting and implications for public health planning
ArticleAbstract: Whole genome sequencing of SARS-CoV-2 has occurred at an unprecedented scale, and can be exploited fPalabras claves:Autores:Aanensen D.M., Aggarwal D., Amato R., Ariani C.V., Barrett J.C., Bashton M., Beckett A.H., Beckwith S.M., Bernardo M. Gutierrez, Bonsall D., Bucca G., Bull M., Burns P.J., Byott M., Carabelli A.M., Carmichael S., Christofidis N., Connor T.R., Corden S., Cortes N., Cottrell S., Curran M.D., de Silva T.I., Eastick K., Enright J., Fairley D.J., Frampton D., Glaysher S., Goldstein E.J., Golubchik T., Goncalves S., Goodfellow I.G., Griffiths E., Gunson R.N., Hamilton W.L., Harrison E.M., Hassan-Ibrahim M.O., Holden M.T.G., Houlihan C., Hughes J., Jackson D.K., Jackson L.M., Johnston I., Kwiatkowski D.P., Langford C.F., Levett L.J., Liggett S., Lillie P.J., Livett R., Loman N.J., Loose M.W., Loveson K.F., Ludden C., Lythgoe K., Mahungu T.W., Moore C., Moore N., Moses S., Murray A., Nastouli E., Nebbia G., Nicholls S.M., Nickbakhsh S., Nomikou K., Nunez R.T.M., Orton R.J., Osman H., O’Grady J., Pacchiarini N., Palmalux N., Parker M.D., Parmar S., Pope C.F., Prieto J.A., Rambaut A., Randell P., Robson S.C., Rogan F., Saeed K., Shaaban S., Shepherd J.G., Sheridan L.A., Sillitoe J., Simpson D.A., Singleton D., Smith C.P., Smith D.L., Smollett K., Snell L.B., Sreenu V.B., Templeton K.E., Thomas C., Thomson E.C., Tomb R.M., Tong L., Torok M.E., Underwood A.P., Wang D., Watkins J., Williams C., Witney A.A.Fuentes:scopusDivergent trajectories of antiviral memory after SARS-CoV-2 infection
ArticleAbstract: The trajectories of acquired immunity to severe acute respiratory syndrome coronavirus 2 infection aPalabras claves:Autores:Abuelgasim H., Adland E., Alexander F., Alhussni A., Ali M., Allott K., Arancibia-Cárcamo C.V., Azim Ansari M., Belij-Rammerstorfer S., Bibi S., Blackwell L., Borak M., Brown A., Brown H., Cassar M.P., Cavell B., Clutterbuck E.A., Conlon C.P., Cutteridge J., de Silva T.I., Deeks A.S., Denly L., Dimitriadis S., Dong T., Duncan C.J.A., Eyre D.W., Fassih S., Flaxman A., Foord T., Fordwoh T., Frater J., Fries A., Goulder P., Grist J., Hackstein C.P., Halkerston R., Harding A.C., Hill J., Ho L.P., Holmes J., Horsington B., James T., Javier Gilbert Jaramillo, Jay C., Jeffery K., Johnson S.A., Kerneis S., Kim D., Knight J.C., Kronsteiner B., Lambe T., Lie Y., Lillie K., Linder A., Longet S., Lumley S.F., Marinou S., Matthews P.C., Mellors J., Mentzer A.J., Moore S.C., Morrow J., Neubauer S., Ogbe A., O’Connor D., O’Donnell D., Pace M., Payne R.P., Peng Y., Petousi N., Petropoulos C., Pollard A.J., Raman B., Richter A., Ritter T.G., Rongkard P., Rowland-Jones S.L., Sedik C., Silva-Reyes L., Simmons B., Skelly D.T., Smith H., Stafford L., Stockdale L., Talbot N.P., Taylor A., Taylor S., Thomas S., Thomas S.R., Tipoe T., Tomic A., Travis S., Turtle L., Vieira V.A., Warren Y., Watson A.J.R., Weeks E., Wilson R., Wrin T., Young R.Fuentes:scopusImmunogenicity of standard and extended dosing intervals of BNT162b2 mRNA vaccine
ArticleAbstract: Extension of the interval between vaccine doses for the BNT162b2 mRNA vaccine was introduced in thePalabras claves:antibody, B cell, BNT162b2, covid-19, dosing interval, Neutralization, SARS-COV-2, T cell, Vaccine, variants of concernAutores:Abuelgasim H., Adele S., Adland E., Adlou S., Akther H.D., Al-Taei S., Alhussni A., Ali M., Altmann T., Amini A., Angyal A., Arancibia-Cárcamo C.V., Austin J.A., Azim Ansari M., Barnes E., Bayley M., Bridges-Webb A., Brown A., Brown H., Brown R., Carroll M.W., Chalk J., Chand M., Chawla A., Chinnakannan S., Conlon C.P., Cross A., Cutteridge J., de Lara C., de Silva T.I., Deeks A.S., Dejnirattisai W., Denly L., Diffey B., Dimitriadis S., Dobson S.L., Dold C., Donnison T., Drake T.M., Dunachie S.J., Duncan C.J.A., Dupont M., Eyre D.W., Fairman A., Faustini S., Foulkes S., Frater J., Gardiner S., Gillson N., Goulder P., Hackstein C.P., Hall V., Hambleton S., Haniffa M., Hargreaves A., Haworth J., Hering L.M., Holmes J., Hopkins S., Horner E., Hornsby H., Jämsén A., Javier Gilbert Jaramillo, Jeffery K., Johnson S.A., Jones C., Kasanyinga M., Kelly S., Kilby J.A., Kirk R., Klenerman P., Knight M.L., Lawrie A., Lee L., Linder A., Longet S., Malone T., Matthews P.C., Meardon N., Mongkolsapaya J., Moore S.C., Nicols A.R., Payne R.P., Phillips E., Pollard A.J., Reyes L.S., Richter A., Rowland-Jones S.L., Saei A., Sandhar G., Screaton G.R., Shields A., Skelly D.T., Stafford L., Supasa P., Tipton T., Turtle L., Tyerman J.K., Whitham R., Wootton D.G.Fuentes:scopusTwo doses of SARS-CoV-2 vaccination induce robust immune responses to emerging SARS-CoV-2 variants of concern
ArticleAbstract: The extent to which immune responses to natural infection with severe acute respiratory syndrome corPalabras claves:Autores:Abuelgasim H., Adele S., Adland E., Adlou S., Alhussni A., Ali M., Amini A., Barnes E., Blackwell L., Bridges-Webb A., Brown A., Brown H., Camara S., Carroll M.W., Cassar M.P., Chinnakannan S., Conlon C.P., Csala A., Cutteridge J., de Lara C., de Oliveira T., de Silva T.I., Deeks A.S., Denly L., Dimitriadis S., Dold C., Dong T., Donnison T., Dunachie S.J., Duncan C.J.A., Edmans M., Frater J., Fries A., Goulder P., Hackstein C.P., Harding A.C., Hill J., Ho L.P., Holmes J., Huang K.Y.A., Hutchings C.L., James W.S., Javier Gilbert Jaramillo, Jay C., Jeffery K., Johnson S.A., Kasanyinga M., Kerneis S., Klenerman P., Knight J.C., Knight M.L., Lee L.N., Li W., Lillie K., Linder A., Longet S., Malone T., Marinou S., Marjot T., Matthews P.C., Mehta H., Mentzer A.J., Moore S.C., Neubauer S., Ogbe A., O’Donnell D., Pace M., Payne R.P., Peng Y., Petousi N., Phalora P., Phillips E., Pollard A.J., Raman B., Richter A., Rijal P., Robinson N., Rongkard P., Schimanski L., Sigal A., Silva-Reyes L., Simmons B., Skelly D.T., Stafford L., Talbot N.P., Tan T.K., Thomas S.R., Tipoe T., Tipton T., Townsend A.R., Turtle L., Watson A.J.R., Weeks E., Wilson R., Zacharopoulou P.Fuentes:scopusRecurrent emergence of SARS-CoV-2 spike deletion H69/V70 and its role in the Alpha variant B.1.1.7
ArticleAbstract: We report severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike ΔH69/V70 in multiple inPalabras claves:Alpha variant, antibody escape, B.1.1.7, covid-19, deletion, infectivity, neutralizing antibodies, RESISTANCE, SARS-COV-2, spike mutationAutores:Aanensen D.M., Aggarwal D., Alderton A., Amato R., Andersson M.I., Ariani C.V., Awan A.R., Barrett J., Bashton M., Bassett A.R., Bernardo M. Gutierrez, Bonsall D., Bucca G., Bull M., Chand M., Chapman M.H.S., Chauhan A.J., Collier D.A., Connor T.R., Constantinidou C., Corden S., Cottrell S., Curran M.D., Darby A.C., Datir R.P., de Silva T.I., Dewar R., Elliott S., Fairley D.J., Ferreira I.A.T.M., Gallo G., Glaysher S., Golubchik T., Goncalves S., Hamilton W.L., Harrison E.M., Harvey W.T., Hassan-Ibrahim M.O., Hiscox J.A., Holden M.T.G., Jackson D.K., Jahun A.S., Jesudason N.G., Johnston I., Kemp S.A., Kwiatkowski D.P., Langford C.F., Lawniczak M., Li K.K., Livett R., Loman N.J., Loose M.W., Loveson K.F., Lowe H., Ludden C., Lytras S., Marelli S., Martincorena I., Martinez Nunez R.T., McCann C.M., McHugh M.P., McKenna J.P., McMurray C., Meng B., Mlcochova P., Mohamed A., Moore C., Moses S., Nelson A., Nicholls S.M., Osman H., O’Grady J., Pacchiarini N., Page A.J., Pandey S., Papa G., Parker M.D., Parmar S., Paterson S., Prieto J.A., Pybus O.G., Rambaut A., Robson S.C., Saeed K., Shah R.N., Shepherd J.G., Sillitoe J., Smith C.P., Smith D.L., Snell L.B., Taha Y., Templeton K.E., Thakur N., Thomson E.C., Torok M.E., Underwood A.P., Unnikrishnan M., Volz E.M., Wang D., Watkins J., Young G.R.Fuentes:scopusSARS-CoV-2 Omicron is an immune escape variant with an altered cell entry pathway
ArticleAbstract: Vaccines based on the spike protein of SARS-CoV-2 are a cornerstone of the public health response toPalabras claves:Autores:Abraham P., Adams H., Adele S., Afifi S., Asamaphan P., Ash A., Ashraf S., Austin J.A., Azim Ansari M., Barnes E., Barrow M., Beckwith S.M., Beer R., Bernardo M. Gutierrez, Bonsall D., Bresner C., Brown A., Buchan S.L., Cantoni D., Connor T.R., Cowton V., Curran T., Cutino-Moguel T., da Silva Filipe A., Davis C., De Lorenzo G., de Silva T.I., Deeks A.S., Dunachie S.J., Duncan C.J.A., Edgeworth J., Fairley D.J., Fraser C., Fryer H., Fuller W., Furnon W., Golubchik T., Grove J., Guest M., Gunson R., Harvey W.T., Holden M.T.G., Holland P., Hughes J., John M., Jones O., Kele B., Kitchen C., Klenerman P., Koshy C., Kronsteiner B., Logan N., Lythgoe K., Mack A., MacLean O.A., Maksimovic J., Manali M., Mantzouratou A., Marchbank A., McCluggage K., McKenna J.P., Merrick I., Moore S.C., Morgan S., Morriss A., Munn R., Murcia P.R., Murray A., Murray S.M., Nebbia G., Orton R.J., Pascall D.J., Patel A., Patel A.H., Patel B., Payne R.P., Pinto R.M., Price A., Puxty K., Reynolds N., Richter A., Scott S., Shaaban S., Silva V., Singleton D., Smollett K., Southgate J., Spellman K., Szemiel A., Templeton K.E., Thomson L., Tong L., Turtle L., Vink E., Warne B., Whalley T., Wilkie C., Willett B.J., Workman T., Yebra G.Fuentes:scopusSARS-CoV-2 lineage dynamics in England from September to November 2021: high diversity of Delta sub-lineages and increased transmissibility of AY.4.2
ArticleAbstract: Background: Since the emergence of SARS-CoV-2, evolutionary pressure has driven large increases in tPalabras claves:covid-19, Delta variant, GENETIC DIVERSITY, mutation, SARS-COV-2, Transmission advantageAutores:Aanensen D.M., Aggarwal D., Amato R., Ariani C.V., Atchison C., Barrett J.C., Bashton M., Beckett A.H., Beckwith S.M., Bernardo M. Gutierrez, Bodinier B., Bonsall D., Bucca G., Bull M., Burns P.J., Byott M., Carabelli A.M., Chand M., Connor T.R., Corden S., Cortes N., Cottrell S., Curran M.D., Darby A.C., De Angelis D., de Oliveira Martins L., de Silva T.I., Eales O., Eastick K., Fairley D.J., Frampton D., Glaysher S., Golubchik T., Goncalves S., Goodfellow I.G., Gunson R.N., Gupta R.K., Hamilton W.L., Harrison E.M., Hassan-Ibrahim M.O., Haw D., Holden M.T.G., Houlihan C., Jackson D.K., Jackson L.M., Johnston I., Jonnerby J., Kwiatkowski D.P., Langford C.F., Levett L.J., Liggett S., Lillie P.J., Livett R., Loman N.J., Loose M.W., Loveson K.F., Ludden C., Lythgoe K., Mahungu T.W., Moore C., Moore N., Moses S., Murray A., Nastouli E., Nebbia G., Nicholls S.M., Nunez R.T.M., Osman H., O’Grady J., Pacchiarini N., Page A.J., Parker M.D., Parmar S., Paterson S., Pope C.F., Prieto J.A., Pybus O.G., Rambaut A., Randell P., Robson S.C., Rogan F., Saeed K., Shepherd J.G., Sheridan L.A., Sillitoe J., Simpson D.A., Singleton D., Smith C.P., Smith D.L., Snell L.B., Templeton K.E., Thomas C., Thomson E.C., Torok M.E., Underwood A.P., Volz E.M., Wang D., Wang H., Watkins J., Williams C., Witney A.A.Fuentes:scopusT-cell and antibody responses to first BNT162b2 vaccine dose in previously infected and SARS-CoV-2-naive UK health-care workers: a multicentre prospective cohort study
ArticleAbstract: Background: Previous infection with SARS-CoV-2 affects the immune response to the first dose of thePalabras claves:Autores:Abuelgasim H., Adland E., Adlou S., Alhussni A., Ali M., Angyal A., Austin J.A., Azim Ansari M., Barnes E., Bayley M., Brown A., Brown H., Brown R., Carroll M.W., Chand M., Chawla A., Conlon C.P., Cross A., Cutteridge J., de Silva T.I., Deeks A.S., Denly L., Diffey B., Dobson S.L., Dold C., Dunachie S.J., Duncan C.J.A., Fairman A., Frater J., Gardiner S., Gillson N., Goulder P., Hall V., Harding A.C., Harrington K., Haworth J., Hering L.M., Holmes J., Hopkins S., Hornsby H., James W.S., Jämsén A., Javier Gilbert Jaramillo, Jeffery K., Jones C., Kasanyinga M., Kilby J.A., Kirk R., Klenerman P., Lawrie A., Lett L., Lillie K., Longet S., Marsh L., Matthews P., Matthews P.C., Meardon N., Mehta H., Moore S.C., Nicols A.R., O'Donnell D., Ogbe A., Pace M., Payne R.P., Platt G., Richter A., Romaniuk L., Rongkard P., Rowland-Jones S.L., Sandhar G., Shields A., Skelly D.T., Smith N., Spegarova J.S., Subramaniam K., Thomas S.R., Tipton T., Tucker S., Turtle L., Turton H., Tyerman J.K., Watson A.J.R., Watson L., Webb-Bridges A., Weeks E., Whitham R., Wilson R., Wood S., Xiao H., Zawia A.Fuentes:scopus